We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 2nd:
Agnico Eagle Mines Limited (AEM - Free Report) : This explorer and developer of mineral properties has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 47.1% over the last 60 days.
Biogen Inc. (BIIB - Free Report) : This developer of innovative therapies for treating serious neurological and neurodegenerative diseases has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.
American International Group, Inc. (AIG - Free Report) : This provider of property-casualty, life and retirement, and general insurance services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.
American International Group, Inc. Price and Consensus
Ally Financial Inc. (ALLY - Free Report) : This digital financial-services company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for August 2nd
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 2nd:
Agnico Eagle Mines Limited (AEM - Free Report) : This explorer and developer of mineral properties has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 47.1% over the last 60 days.
Agnico Eagle Mines Limited Price and Consensus
Agnico Eagle Mines Limited price-consensus-chart | Agnico Eagle Mines Limited Quote
Agnico Eagle's shares gained 5.8% over the last one month compared to S&P 500’s fall of -1.8%. The company possesses a Momentum Score of A.
Agnico Eagle Mines Limited Price
Agnico Eagle Mines Limited price | Agnico Eagle Mines Limited Quote
Biogen Inc. (BIIB - Free Report) : This developer of innovative therapies for treating serious neurological and neurodegenerative diseases has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.
Biogen Inc. Price and Consensus
Biogen Inc. price-consensus-chart | Biogen Inc. Quote
Biogen's shares gained 2.1% over the last one month. The company possesses a Momentum Score of A.
Biogen Inc. Price
Biogen Inc. price | Biogen Inc. Quote
American International Group, Inc. (AIG - Free Report) : This provider of property-casualty, life and retirement, and general insurance services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.
American International Group, Inc. Price and Consensus
American International Group, Inc. price-consensus-chart | American International Group, Inc. Quote
American International’s shares gained 0.8% over the last one month. The company possesses a Momentum Score of A.
American International Group, Inc. Price
American International Group, Inc. price | American International Group, Inc. Quote
Ally Financial Inc. (ALLY - Free Report) : This digital financial-services company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Ally Financial Inc. Price and Consensus
Ally Financial Inc. price-consensus-chart | Ally Financial Inc. Quote
Ally’s shares gained 2.5% over the last one month. The company possesses a Momentum Score of B.
Ally Financial Inc. Price
Ally Financial Inc. price | Ally Financial Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>